# RhEGF Incorporated in An Absorbable Collagen Membrane for The Management Of Gingival Recession Defects

> **NCT04375618** · PHASE1 · UNKNOWN · sponsor: **SVS Institute of Dental Sciences** · enrollment: 30 (estimated)

## Conditions studied

- Periodontitis

## Interventions

- **DRUG:** RhEGF
- **DRUG:** Plain Collagen

## Key facts

- **NCT ID:** NCT04375618
- **Lead sponsor:** SVS Institute of Dental Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-10-01
- **Primary completion:** 2020-10
- **Final completion:** 2021-11
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2020-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04375618

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04375618, "RhEGF Incorporated in An Absorbable Collagen Membrane for The Management Of Gingival Recession Defects". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04375618. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*